News|Articles|December 4, 2013
The Impact of Biosimilars on the Innovator Market
Author(s)Pharmaceutical Technology Editors
Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing
Advertisement
Jill E. Sackman, D.V.M., PhD, senior consultant atNumerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing.
For more videos tune in to:
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Women in STEM: Inspiration from Innovators in Pharma
3
Six New Approvals and Nine Indication Extensions from EMA’s CHMP
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5